Internal Medicine, Hematology & Oncology · Springfield, IL
NPI
1760414437
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
900 N 1st St
Springfield, IL, 62702
Phone (217) 528-7541
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
142,686 services
Medicare patients, 2024
429
Average age 73
Drug cost, 2024
$3.4M
1,497 prescriptions
Company payments, 2025
$1,192
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Praveen Garg was code J9271 (injection, pembrolizumab, 1 mg), 22,800 times for 21 patients. In total Praveen Garg billed 142,686 services in 115 codes, and Medicare paid $2.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 22,800 | 21 | $44.33 | $1.0M |
| J1756 Injection, iron sucrose, 1 mg | Office | 17,000 | 31 | $0.18 | $2,990 |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 11,730 | 11 | $0.28 | $3,260 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 9,900 | 14 | $0.10 | $952 |
| J9267 Injection, paclitaxel, 1 mg | Office | 6,841 | 15 | $0.08 | $523 |
| J0897 Injection, denosumab, 1 mg | Office | 5,760 | 17 | $20.59 | $119K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,957 | 45 | $0.08 | $161 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,280 | 31 | $0.68 | $876 |
| 99214 Office E&M - Established | Office | 754 | 289 | $90.91 | $69K |
| 85025 Blood Count | Office | 607 | 225 | $7.60 | $4,613 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 590 | 95 | $0.50 | $297 |
| 36415 Venipuncture Blood Collection | Office | 530 | 229 | $8.02 | $4,251 |
| J9045 Injection, carboplatin, 50 mg | Office | 404 | 19 | $2.83 | $1,145 |
| 96375 Injection Administration | Office | 351 | 49 | $11.11 | $3,901 |
| 96413 Chemotherapy Administration | Office | 336 | 67 | $89.98 | $30K |
By year: 2022 $1.3M for 125,181 services; 2023 $1.3M for 95,189 services; 2024 $2.2M for 142,686 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 607 | 225 | $7.60 | $4,613 |
| 36415 Venipuncture Blood Collection | 530 | 229 | $8.02 | $4,251 |
| 80047 Clinical Chemistry | 236 | 51 | $13.46 | $3,177 |
Medicare prescription drug claims, 2024
In 2024, the drug Praveen Garg prescribed most often to Medicare patients was Anastrozole, with 245 prescriptions and refills. In total Praveen Garg wrote 1,497 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 245 | 659 | 68 | $3,677 |
| Eliquis Apixaban | 134 | 185 | 26 | $107K |
| Ondansetron Hcl Generic | 74 | 74 | 45 | $554 |
| Prochlorperazine Maleate Generic | 73 | 73 | 55 | $1,529 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 58 | 60 | 45 | $612 |
| Ondansetron Odt Ondansetron | 47 | 48 | 23 | $1,016 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 39 | 39 | 20 | $1,476 |
| Tramadol Hcl Generic | 34 | 35 | 19 | $623 |
| Gabapentin Generic | 32 | 45 | 13 | $702 |
| Tamoxifen Citrate Generic | 31 | 91 | Under 11 | $561 |
| Hydroxyurea Generic | 31 | 68 | Under 11 | $368 |
| Imatinib Mesylate Generic | 31 | 31 | Under 11 | $103K |
| Letrozole Generic | 29 | 81 | Under 11 | $342 |
| Prednisone Generic | 28 | 32 | 19 | $158 |
| Potassium Chloride Generic | 27 | 43 | 15 | $361 |
Brand drugs: 346 claims; generic drugs: 1,151 claims; opioid claims: 121.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Praveen Garg $1,192 ($1,192 in general payments such as food, travel and fees) from 18 companies. The largest payer was Astellas Pharma US Inc with $285.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 8 | $285 |
| Janssen Biotech, Inc. JNJ | 9 | $141 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $85.8 |
| Pfizer Inc. PFE | 3 | $83.03 |
| Gilead Sciences, Inc. GILD | 4 | $75.27 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $69.96 |
| Daiichi Sankyo Inc. 4568.T | 2 | $67.7 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $64.32 |
| Abbvie Inc. ABBV | 2 | $60.63 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $56.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.